The PT-approved weighted walking routine all midlife women need – your beginner's guide - Women's Health
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Mareen FischingerJump to:Why is weighted walking effective? Everything you need to know to get startedA beginner-friendly weekly weighted walking routineThe bottom lineWeighted walking is having a moment right now – according to Google Trends, UK-based searches of the term are up by more than 5,000% in the last three months compared with the same period last year. The current buzz around this specific workout, says strength and menopause coach Alice Jordan, likely relates to (busy) people realising just how convenient and effective it is. Why is weighted walking effective? ‘Weighted walking is a really accessible way of making a normal walk more challenging without having to run or completely change your routine,’ she says. ‘By adding load, you increase the demand on your muscles and cardiovascular system, so your heart rate and energy expenditure can increase even at the same walking speed.’‘Research shows that weighted vests can increase the metabolic cost [the amount of energy your body uses to perform an activity] of walking,’ notes Jordan.
This article is an excerpt. To read the full content, visit the original source. Women's Health
Related articles
Are weighted blankets really beneficial? - The Economist
Bioengineer.org | Viral blips during HIV therapy are common and rarely signal treatment failure, Swedish study finds - European AIDS Treatment Group
Bioengineer.org news storyFor people living with HIV, modern antiretroviral therapy can suppress the virus to levels below what standard laboratory tests can detect. Yet some patients on long-term treatment experience a curious phenomenon: a single test result showing a small, transient amount of virus in the blood, followed by an immediate return to undetectable levels. These events, known as viral blips, have puzzled clinicians and researchers for years, raising questions about whether they represent harmless statistical noise, brief bursts of viral production from hidden reservoirs, or early warnings of impending treatment failure. A new nationwide Swedish study, published in BMC Infectious Diseases, offers one of the most comprehensive answers to date. Drawing on the Swedish national InfCareHIV cohort, researchers analyzed data from 4,210 treatment-naïve adults who began antiretroviral therapy from 1 January 2007 onward, with follow-up data extracted through 30 September 2020. The median observation time was 5.5 years, with some individuals followed for as long as 13.7 years.
0 comments
No comments yet. Be the first to share your thoughts!